Is CI a buy?
Gabriel Cooper
Updated on February 09, 2026
Is CI a buy?
Out of 11 analysts, 5 (45.45%) are recommending CI as a Strong Buy, 4 (36.36%) are recommending CI as a Buy, 2 (18.18%) are recommending CI as a Hold, 0 (0%) are recommending CI as a Sell, and 0 (0%) are recommending CI as a Strong Sell. What is CI’s earnings growth forecast for 2021-2023?
How many customers does Cigna have?
With more than 180 million customer and patient relationships in more than 30 countries and jurisdictions, we are able to harness actionable insights that address whole-person health and drive better health outcomes.
What companies does Cigna own?
Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Cigna HealthCare of Arizona, Inc., Cigna HealthCare of Illinois, Inc., or Cigna HealthCare of North Carolina, Inc. Tel-Drug, Inc. and Tel-Drug of Pennsylvania, L.L.C.
Is CI a good stock to buy?
Compared to these stocks Cigna Corporation (NYSE:CI) is more popular among hedge funds. Our overall hedge fund sentiment score for CI is 69.5. Stocks with higher number of hedge fund positions relative to other stocks as well as relative to their historical range receive a higher sentiment score.
Is Cigna a good employer?
Great Company to work for. Salary is competitive as well. Lots of opportunity for growth and development. The company is stable and provides good benefits and wages. As well as opportunities for growth.
Who are Cigna competitors?
Cigna Corporation competitors include UnitedHealth Group, CVS Health and Aetna.
What are the 2 companies that form Cigna?
Cigna was formed by the 1982 merger of the Connecticut General Life Insurance Company (CG) and INA Corporation (the parent corporation of Insurance Company of North America, the first stock insurance company in America). The company name, Cigna, is a mix of letters from the merging companies, CG and INA.
Is Cigna stock a buy or sell?
Cigna has received a consensus rating of Buy. The company’s average rating score is 2.93, and is based on 11 buy ratings, 2 hold ratings, and no sell ratings.
Will Humana stock go up?
Stock Price Forecast The 20 analysts offering 12-month price forecasts for Humana Inc have a median target of 499.00, with a high estimate of 525.00 and a low estimate of 427.00. The median estimate represents a +20.30% increase from the last price of 414.78.
How much PTO does Cigna give?
Time away from work is essential to recharge your batteries, focus on your family and hobbies, and come back to work refreshed and ready to make an impact. That’s why we offer 18 days of PTO to start, plus paid holidays, caregiver leave, bought time off, company paid volunteer community service hours, and more.
How much does Cigna match 401K?
The match is 3.5%.
Is Cigna a good company?
We award Cigna 2.5 out of 5.0 stars. Cigna is one of the largest health insurers in the US, and is highly rated by AM Best and the BBB. The company offers a variety of health plans for employer groups, as well as plans for individuals and families.
What is the stock price of CIGNA Corporation?
Cigna’s (NYSE:CI) International Markets business today published the second edition of its COVID-19 Vaccine Perception Study which shows that overall rates of vaccines acceptance have increased from 63% to 66% in a single month.
What kind of return do you expect from CIGNA?
Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. CI: What does Argus have to say about CI?
What kind of health insurance does Cigna offer?
Cigna (CI) joins forces with Oscar Health to extend its health insurance product to small business units across Arizona.
How is the market cap of Agilent Technologies determined?
“Market Cap” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements.
Cigna’s (NYSE:CI) International Markets business today published the second edition of its COVID-19 Vaccine Perception Study which shows that overall rates of vaccines acceptance have increased from 63% to 66% in a single month.
Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. CI: What does Argus have to say about CI?
Cigna (CI) joins forces with Oscar Health to extend its health insurance product to small business units across Arizona.